Do online doctors check PMP for Mounjaro?

If you’re considering GLP-1 medications like Wegovy, Ozempic, or Mounjaro for weight management, you might be wondering: Can I get these prescriptions through a telehealth appointment? The short answer is yes—in most cases, you absolutely can. But as with many aspects of healthcare, the details depend on where you live and how you access care.

This comprehensive guide will walk you through everything you need to know about getting weight loss medications via telehealth in 2025, including federal and state regulations, what to expect from your virtual visit, and how to find safe, legitimate telehealth providers.

Understanding Telehealth Prescribing for Weight Loss Medications

The Federal Picture: GLP-1s Are Not Controlled Substances

Here’s an important fact that makes telehealth weight loss treatment possible: medications like Wegovy, Ozempic, and Mounjaro are not controlled substances under federal law. This is a crucial distinction.

The Ryan Haight Act—federal legislation designed to prevent online ‘pill mills’—requires an in-person medical examination before prescribing controlled substances (like Adderall or opioids) via telemedicine. However, this law does not apply to GLP-1 receptor agonists used for weight management. Since semaglutide and tirzepatide aren’t classified as controlled drugs, there’s no federal barrier preventing licensed providers from prescribing them after a legitimate telehealth consultation.

During the COVID-19 pandemic, the DEA temporarily waived even the controlled substance in-person requirement. That flexibility has been extended through December 31, 2025, but it’s worth noting this extension primarily affects medications like ADHD treatments or addiction medications—not the weight loss drugs we’re discussing here, which were already eligible for telehealth prescribing.

State Regulations: Where the Real Differences Lie

While federal law permits telehealth prescribing of GLP-1 medications, individual states add their own requirements. Some states have embraced telehealth fully, allowing providers to prescribe these medications after a thorough video consultation. Others require an initial in-person examination or ongoing in-person follow-ups.

The variation isn’t arbitrary—state medical boards set these standards to ensure patient safety and appropriate care. Understanding your state’s specific rules will help you know what to expect when seeking telehealth weight loss treatment.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

What Makes You Eligible for GLP-1 Weight Loss Medications?

Before we dive into state-specific regulations, let’s clarify who actually qualifies for these medications. Reputable telehealth providers won’t simply hand out prescriptions to anyone who asks—and they shouldn’t.

Clinical Criteria

According to FDA guidelines, anti-obesity medications like Wegovy are generally prescribed for:

• Adults with a BMI of 30 or higher (classified as obese), OR
• Adults with a BMI of 27 or higher who also have at least one weight-related health condition such as type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea

Your telehealth provider will calculate your BMI based on your height and current weight. They’ll also review your medical history to identify any weight-related health conditions that might make treatment appropriate even if your BMI is slightly lower.

Important Contraindications

Not everyone can safely take GLP-1 medications. During your telehealth evaluation, you’ll be screened for contraindications including:

• Personal or family history of medullary thyroid carcinoma (a rare type of thyroid cancer)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Pregnancy or plans to become pregnant (these medications must be stopped at least 2 months before conception)
• History of pancreatitis or severe gallbladder disease
• Severe gastroparesis or other significant gastrointestinal disorders

If any of these apply to you, your provider will discuss alternative weight management approaches.

The Lifestyle Component

Here’s something many people don’t realize: GLP-1 medications are meant to work alongside lifestyle changes, not replace them. Legitimate telehealth providers will:

• Ask about your current diet and exercise habits
• Discuss realistic lifestyle modifications you can implement
• Provide or recommend nutritional counseling
• Set expectations for gradual, sustainable weight loss (typically 1-2 pounds per week)

If a telehealth service promises dramatic results without mentioning diet and exercise, that’s a significant red flag.

State-by-State Telehealth Prescribing Guide

Let’s break down what you can expect in different states. Keep in mind that even in states with stricter requirements, telehealth weight loss treatment is still possible—you just might need to coordinate an initial in-person visit or follow specific protocols.

States With Full Telehealth Access (No In-Person Requirement)

Several states allow providers to prescribe GLP-1 weight loss medications entirely through telehealth, with no mandated in-person visits:

California leads the pack with progressive telehealth laws. Nurse practitioners in California also have full independent practice authority, meaning you might see an NP for your consultation—and that’s completely legitimate and legal.

Washington has been a telehealth pioneer for years. The state fully embraces virtual care for weight management, and like California, allows NPs to practice independently. One thing to note: Washington’s ‘My Health My Data Act’ (passed in 2023) imposes strict privacy requirements on telehealth providers, which is actually good news for patients concerned about sensitive health information.

New York permits telehealth prescribing of weight loss medications without requiring in-person visits. NPs in New York can practice independently after completing 3,600 hours of supervised experience, so many telehealth platforms utilize NPs for these consultations.

Illinois has made telehealth permanent in state law and requires e-prescribing for all medications (including GLP-1s), which actually helps ensure proper documentation and pharmacy verification.

Connecticut allows telehealth weight loss treatment but adds one important requirement: providers must include behavioral counseling and a diet/exercise plan as part of obesity treatment. This is actually consistent with best practices, so you should expect this from quality providers anyway.

Pennsylvania permits telehealth prescribing without in-person mandates, though NPs still work under physician collaboration in PA (independent practice legislation has been pending for years).

States Requiring an Initial In-Person Visit

Several states want to see patients in person at least once before or shortly after starting weight loss medication via telehealth:

Arkansas has some of the nation’s strictest telemedicine regulations. An initial in-person examination is required to establish the patient-provider relationship before prescribing can occur via telehealth. However, proposals to ease these restrictions were under review in late 2025, so this may become more flexible.

Delaware requires providers to perform an initial physical examination in person before beginning telehealth-based weight loss treatment. After that first visit, ongoing care and prescription refills can happen virtually.

Georgia implemented new rules requiring an initial in-person exam for weight management prescriptions. On the positive side, Georgia recently passed legislation (effective July 2024) allowing nurse practitioners and physician assistants to prescribe Schedule II controlled substances with physician delegation—a sign the state is becoming more flexible about provider qualifications.

Mississippi maintains an initial in-person evaluation requirement for weight management therapy. The state is also considering legislation to grant nurse practitioners full independent practice authority, which could expand telehealth access in the future.

New Jersey takes a comprehensive approach: state law requires an extensive initial evaluation including a complete physical exam, laboratory testing, and psychological screening before prescribing any weight-loss medication. Providers must also document informed consent covering all risks. While this might seem burdensome, it reflects a commitment to thorough, safe care.

North Dakota expects a hands-on initial evaluation for weight loss treatment, though the state is otherwise very telehealth-friendly (NPs have full practice authority there).

South Carolina requires an initial in-person visit and periodic evaluations for patients on weight management medications. NPs and PAs can prescribe with physician oversight and a written protocol.

Texas generally expects an initial in-person exam before beginning telehealth weight loss treatment. Texas also has strict rules about prescriptive authority: nurse practitioners must have a physician delegation agreement and cannot practice independently. However, GLP-1 medications themselves (being non-controlled) don’t face additional restrictions beyond the standard of care.

Utah encourages an initial in-person examination, though the state has recently expanded NP autonomy (as of 2023, NPs can practice independently). After the baseline visit, ongoing telehealth care is fully supported.

Virginia requires a comprehensive initial work-up: physical examination, laboratory testing, and a documented diet and exercise plan. The state also mandates a follow-up visit within 30 days of starting therapy. While detailed, these requirements ensure thorough monitoring. Virginia NPs can practice independently after two years of collaborative experience.

States With Specific Clinical Requirements

Florida doesn’t prohibit telehealth prescribing but adds specific conditions:

• Patients must have a BMI of at least 30
• Follow-up visits are required at least every 3 months during treatment
• NPs have limited independence (mainly in primary care settings)

These rules essentially codify what should be standard practice anyway—regular monitoring is crucial when taking these medications.

What About Provider Qualifications?

One common question: Does it matter if I see a doctor versus a nurse practitioner for my telehealth visit?

The answer depends on your state, but in most cases, no—it doesn’t matter, as long as the provider is properly licensed and credentialed.

Physicians (MDs and DOs) can prescribe GLP-1 weight loss medications via telehealth in all states, assuming they hold a valid license in the state where you’re physically located during the consultation.

Nurse Practitioners (NPs) can also prescribe these medications, but their level of autonomy varies:

• In 34 states plus DC (as of 2025), NPs have full practice authority and can prescribe independently without physician oversight
• In other states, NPs work under collaborative agreements or supervision with physicians—but can still prescribe GLP-1 medications for weight loss

Physician Assistants (PAs) can prescribe in all states but typically work under physician supervision or collaborative protocols.

At Klarity Health, we ensure all providers—whether MDs, DOs, NPs, or PAs—are appropriately licensed in your state and meet all regulatory requirements. When you connect with a provider, you can be confident they’re legally authorized to treat you.

What to Expect From Your Telehealth Weight Loss Consultation

The Initial Evaluation

A legitimate telehealth visit for weight loss medication should be comprehensive, not a rubber-stamp prescription service. Here’s what a typical initial consultation includes:

1. Detailed Medical HistoryYour provider will ask about:

• Current and past medical conditions
• All medications you’re currently taking (including supplements)
• Previous weight loss attempts and results
• Family medical history, especially thyroid or endocrine conditions
• Any history of eating disorders or significant mental health conditions

2. Physical AssessmentEven though the visit is virtual, your provider will:

• Calculate your BMI based on your self-reported height and current weight
• Ask about recent vital signs (blood pressure, heart rate)
• Inquire about any current symptoms or concerns
• In some cases, request recent lab work or ask you to get labs done

Some states require verification of your weight—this might mean stepping on a scale during your video visit or providing recent documentation from another healthcare visit.

3. Lifestyle DiscussionExpect questions about:

• Your typical daily diet and eating patterns
• Physical activity levels and exercise routines
• Sleep quality and stress levels
• Support system and motivation for weight loss

4. Informed ConsentYour provider should clearly explain:

• How the medication works
• Common side effects (nausea, diarrhea, constipation, stomach pain)
• Serious but rare risks (pancreatitis, gallbladder issues, potential thyroid effects)
• The importance of combining medication with lifestyle changes
• What to do if you experience side effects

5. Treatment Plan DevelopmentTogether, you’ll establish:

• Starting dose and titration schedule (GLP-1 medications typically start low and gradually increase)
• Follow-up schedule
• Specific diet and exercise goals
• When to contact your provider with concerns

Follow-Up Care

Weight loss medication isn’t a ‘set it and forget it’ treatment. Reputable telehealth providers will schedule regular follow-ups:

• 1 month after starting: Check tolerance, assess early side effects, discuss any dose adjustments
• Every 2-3 months ongoing: Monitor weight loss progress, review side effects, adjust dosing if needed, check on lifestyle adherence

Some states legally require these follow-ups (like Florida’s every-3-month rule), but they’re medically necessary regardless of legal requirements.

Getting Your Prescription

After your provider determines you’re a good candidate, they’ll send your prescription electronically to your pharmacy of choice. A few important points:

• No compounded versions: As of May 2025, the FDA banned most compounding of semaglutide. Your prescription will be for FDA-approved brand-name medications (Wegovy, Ozempic, Mounjaro/Zepbound)
• Initial supply: First prescriptions are often for 4 weeks to assess tolerance
• Ongoing refills: Subsequent prescriptions might cover 1-3 months depending on your state’s regulations and your insurance

Supply duration varies: Unlike controlled substances (which have federal limits on quantity), there’s no federal cap on how much GLP-1 medication can be prescribed at once. However, many providers stick to monthly or quarterly refills to ensure regular monitoring.

Red Flags: How to Spot Illegitimate Telehealth Services

The popularity of weight loss medications has unfortunately attracted some less-than-reputable players. Here’s what to watch out for:

Guaranteed Prescriptions

If a service promises you’ll get a prescription before you’ve even had a consultation, run away. Legitimate providers assess each patient individually—some people won’t qualify for medical reasons, and that’s okay.

Compounded or ‘Generic’ Semaglutide

As of 2025, FDA-approved semaglutide should come from licensed pharmacies dispensing brand-name Wegovy or Ozempic. Be very cautious of services offering significantly cheaper ‘compounded’ versions, especially from overseas sources. The FDA cracked down on compounding due to safety and quality concerns.

No Real Medical Evaluation

Red flag if a service:

• Only asks a few basic questions via an online form
• Doesn’t require a live video consultation
• Doesn’t ask about contraindications or medical history
• Skips discussing risks and side effects

Missing Provider Information

Legitimate telehealth platforms are transparent about:

• Who your provider is (name, credentials)
• What state(s) they’re licensed in
• How to contact them with follow-up questions

If this information is vague or hidden, be suspicious.

No Follow-Up Plan

Weight loss medication requires ongoing monitoring. If a service just sends you a prescription and disappears, that’s dangerous. You should have a clear plan for follow-up visits and a way to reach your provider between appointments.

Pressure Tactics or Unrealistic Promises

Be wary of services that:

• Claim you’ll lose dramatic amounts of weight quickly
• Pressure you to commit to long-term payment plans upfront
• Downplay side effects or risks
• Suggest you don’t need diet and exercise changes

How Klarity Health Approaches Telehealth Weight Loss Treatment

At Klarity Health, we’ve built our telehealth weight management program around safety, legitimacy, and patient support.

Our Approach

Comprehensive Evaluations: Every patient has a live video consultation with a licensed provider (MD, DO, or NP) who conducts a thorough medical assessment before prescribing.

State-Licensed Providers: We ensure our providers are licensed in your state and follow all local regulations—whether that means arranging an initial in-person exam in states that require it, or providing fully virtual care where permitted.

Transparent Pricing: We accept both insurance and offer clear cash-pay pricing. No surprise fees or hidden costs. You’ll know exactly what you’re paying upfront.

Provider Availability: Finding a provider who can see you shouldn’t take weeks. We prioritize quick access to consultations while maintaining thorough care standards.

Ongoing Support: Weight loss is a journey, not a one-time event. Our providers schedule regular follow-ups to monitor your progress, adjust treatment as needed, and provide encouragement along the way.

FDA-Approved Medications Only: We prescribe only FDA-approved, brand-name medications through licensed U.S. pharmacies. No compounded versions or overseas sources.

Beyond Just Medication

We recognize that medication is just one tool in sustainable weight management. Our providers will:

• Discuss realistic dietary changes you can maintain long-term
• Encourage physical activity appropriate for your fitness level
• Address behavioral aspects of eating and weight management
• Coordinate with your other healthcare providers as needed

Think of GLP-1 medications as giving you a boost—they reduce appetite and help you feel full sooner, making it easier to stick with healthy habits. But the habits themselves are what create lasting change.

Insurance Coverage and Cost Considerations

Insurance Coverage

Many insurance plans now cover GLP-1 medications for weight loss, but coverage varies widely:

• Medicare: Currently does not cover weight loss medications (though this may change with pending legislation)
• Private insurance: Increasing numbers of plans cover Wegovy specifically for obesity; Ozempic is usually covered for diabetes (off-label weight loss use may not be covered)
• Medicaid: Varies by state; some state Medicaid programs cover weight loss medications, others don’t

At Klarity Health, our team can help verify your insurance coverage before your appointment, so you know what to expect cost-wise.

Cash-Pay Options

If insurance doesn’t cover your medication or if you prefer to pay out of pocket, we offer transparent cash-pay pricing for both consultations and medications. Additionally:

• Manufacturer savings programs may be available (check the Wegovy or Mounjaro websites)
• Some pharmacies offer discount programs
• GoodRx and similar services can help reduce costs at certain pharmacies

The medication itself is typically the largest expense (often $900-$1,300 per month at retail prices without insurance). Telehealth consultation fees are usually far more modest—often $50-$150 for initial visits and less for follow-ups.

Looking Ahead: The Future of Telehealth Weight Loss Treatment

Regulatory Trends

The trajectory is clearly toward greater access to telehealth for weight management:

• More states are granting nurse practitioners full practice authority, expanding the provider pool
• Interstate licensure compacts are making it easier for providers to treat patients across state lines
• Federal legislation like the TREATS Act (if passed) would further cement telehealth flexibility

Clinical Advances

New weight loss medications are in development, and existing ones continue to show impressive results in clinical trials:

• Longer-acting formulations that might require less frequent injections
• Oral GLP-1 medications (already available for diabetes, being studied for weight loss)
• Combination therapies targeting multiple pathways

As these options expand, telehealth will remain crucial for ensuring patients across the country—especially in underserved areas—can access them.

Patient Empowerment

Telehealth fundamentally changes the dynamic of healthcare. Instead of battling traffic, taking time off work, and sitting in waiting rooms, you can connect with a qualified provider from your home. For weight management—a sensitive topic many people find difficult to discuss—the privacy and convenience of telehealth can be particularly valuable.

Take the Next Step

If you’ve been struggling with your weight and wondering if GLP-1 medications might help, telehealth makes it easier than ever to find out. The key is choosing a legitimate, safety-focused provider who will thoroughly evaluate your situation and support you throughout your weight loss journey.

Ready to explore whether telehealth weight loss treatment is right for you? Klarity Health offers comprehensive evaluations with licensed providers in most states. We’ll help you understand your options, navigate any state-specific requirements, and develop a personalized treatment plan that includes both medication (if appropriate) and lifestyle support.

Visit Klarity Health today to schedule your confidential consultation and take the first step toward sustainable weight management.

Frequently Asked Questions

Q: Is telehealth weight loss treatment as effective as in-person care?

A: Research shows telehealth can be just as effective as in-person care for weight management when proper protocols are followed. The key is choosing a provider who conducts thorough evaluations, provides ongoing monitoring, and doesn’t just hand out prescriptions without appropriate assessment and follow-up.

Q: How quickly can I get a prescription through telehealth?

A: If you’re medically eligible, many patients can have a prescription sent to their pharmacy within 24-48 hours of their initial consultation. However, in states requiring an initial in-person visit, you’ll need to coordinate that first before receiving your prescription.

Q: What if I move to a different state while on treatment?

A: You’ll need to ensure your provider is licensed in your new state. Some telehealth platforms (including Klarity Health) have providers in multiple states, making transitions easier. You may need a new initial consultation with a provider licensed in your new location.

Q: Can I switch from in-person weight loss treatment to telehealth?

A: Absolutely. If you’re already established on a GLP-1 medication through in-person care, transitioning to telehealth for ongoing management is typically straightforward. Your new telehealth provider will review your treatment history and continue your care.

Q: What happens if I experience side effects?

A: Contact your provider immediately. Most telehealth platforms offer messaging or phone support between scheduled visits. Common side effects like mild nausea often improve as your body adjusts, but your provider may need to adjust your dose or, in rare cases, discontinue the medication.

📅 RESEARCH CURRENCY STATEMENT
Verified as of: December 17, 2025
DEA Rules Status: DEA’s COVID-era telehealth flexibilities remain in effect through December 31, 2025. Non-controlled medications (like GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person rule, so they can be prescribed via telehealth under federal law.
States Verified: AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA (as of Dec 2025)

Sources and References

1. DEA and HHS Extend Telemedicine Flexibilities through 2025 – Official DEA announcement (November 15, 2024) www.dea.gov

2. COVID-era telehealth prescribing extended – Axios News (November 18, 2024) www.axios.com

3. DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025 – McDermott Will & Emery Legal Analysis (November 18, 2024) www.mwe.com

4. The Changing Regulatory and Reimbursement Landscape for Weight Loss Drugs – Goodwin Procter Client Alert (March 27, 2024) www.goodwinlaw.com

5. Know Your State’s Laws Around Semaglutide – Nextech Healthcare Industry Blog (April 11, 2025) www.nextech.com

This article is for informational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider about your specific situation and treatment options.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid